HLB PHARMACEUTICAL CO., LTD. Logo

HLB PHARMACEUTICAL CO., LTD.

Researches cancer drugs and offers pharmaceutical CMO and manufacturing services.

047920 | KO

Overview

Corporate Details

ISIN(s):
KR7047920004
LEI:
Country:
South Korea
Address:
경기도 남양주시 경강로 27, 남양주시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

HLB Pharmaceutical Co., Ltd. is a research-driven pharmaceutical company specializing in the development and manufacturing of innovative treatments. The company's core activities center on researching and developing new drugs, including peptide-based therapies and a pipeline of anti-cancer treatments, as part of its vision to become a global oncology firm. In addition to its R&D, HLB Pharmaceutical provides Contract Manufacturing Organization (CMO) services, utilizing its advanced facilities and rigorous quality management systems to produce high-quality medicines. The company also manufactures quasi-drugs, such as alcohol swabs for disinfecting wounds and sterilizing medical devices, and its portfolio includes products like skeletal muscle relaxants.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-02 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 105.6 KB
2025-08-21 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 105.6 KB
2025-08-13 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.6 MB
2025-07-23 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 105.6 KB
2025-07-03 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 105.7 KB
2025-06-27 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 6.7 KB
2025-06-25 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 6.7 KB
2025-06-11 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 6.7 KB
2025-06-04 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 103.9 KB
2025-05-29 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 103.7 KB
2025-05-29 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.3 KB
2025-05-14 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.0 MB
2025-05-08 00:00
Share Issue/Capital Change
증권발행결과(자율공시)
Korean 5.7 KB
2025-04-24 00:00
M&A Activity
주요사항보고서(타법인주식및출자증권양수결정)
Korean 34.7 KB
2025-04-24 00:00
Share Issue/Capital Change
주요사항보고서(유상증자결정)
Korean 39.9 KB

Automate Your Workflow. Get a real-time feed of all HLB PHARMACEUTICAL CO., LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for HLB PHARMACEUTICAL CO., LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for HLB PHARMACEUTICAL CO., LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Active Biotech Logo
Develops immunology-based drugs for cancer and inflammatory diseases with high unmet medical need.
Sweden
ACTI
ACTUATE THERAPEUTICS, INC. Logo
Clinical-stage biopharma developing a novel GSK-3 inhibitor for hard-to-treat cancers.
United States of America
ACTU
AcuCort AB Logo
Develops a rapid oral film for acute allergies, croup, and chemo-induced nausea.
Sweden
ACUC
Acurx Pharmaceuticals, Inc. Logo
Developing a new class of antibiotics to treat priority Gram-positive bacterial infections.
United States of America
ACXP
Adagene Inc. Logo
Develops novel antibody-based immunotherapies for cancer using an AI-driven discovery platform.
United States of America
ADAG
Adaptimmune Therapeutics PLC Logo
Develops novel T-cell therapies to treat solid tumors by engineering a patient's own immune cells.
United States of America
ADAP
ADBIOTECH Co.,Ltd. Logo
Develops egg-based IgY antibodies as vaccine/antibiotic alternatives for animal and human health.
South Korea
179530
ADC Therapeutics SA Logo
Develops targeted antibody-drug conjugates for hematological and solid tumors.
United States of America
ADCT
ADIAL PHARMACEUTICALS, INC. Logo
Develops personalized, genetically-targeted drugs for treating Alcohol Use Disorder and addiction.
United States of America
ADIL
Adicet Bio, Inc. Logo
Developing off-the-shelf gamma delta T cell therapies for cancer and autoimmune diseases.
United States of America
ACET

Talk to a Data Expert

Have a question? We'll get back to you promptly.